Conference Description
The Hormone-Dependent Cancers GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
The 2023 Gordon Research Conference on Hormone-Dependent Cancers: Understanding and Exploiting Genomic Aberrations and Microenvironmental Adaptations will provide a forum to discuss novel state-of-the-art approaches to decipher genomic drivers of heterogeneity and disease progression.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by April 8, 2023. Please check back for updates.
Keynote Session: Advances in Targeting Steroid Receptors
Discussion Leaders
-
Wayne Tilley (University of Adelaide, Australia)
Speakers
-
Geoffrey Greene (University of Chicago, United States)
-
Steffi Oesterreich (UPMC Hillman Cancer Center , United States)
-
Karen Knudsen (American Cancer Society, United States)
DNA Repair Deficiency in Hormone-Dependent Cancers
Discussion Leaders
-
Steve Balk (Beth Israel Deaconess Medical Center, United States)
Speakers
-
Luc Furic (Peter MacCallum Cancer Centre, Australia)
-
Peter Nelson (Fred Hutchinson Cancer Center, United States)
-
Robert Bristow (University of Manchester, United Kingdom)
Cancer Genomics and Genetics
Discussion Leaders
-
Alex Swarbrick (Garvan Institute of Medical Research, Australia)
-
Scott Dehm (University of Minnesota, United States)
Speakers
-
Adrian Lee (UPMC Hillman Cancer Center, United States)
-
David Quigley (University of California San Francisco, United States)
-
Housheng He (Princess Margaret Cancer Center, University of Toronto, Canada)
-
Jay Gertz (University of Utah, United States)
Drivers of Heterogeneity and Progression in Hormone-Dependent Cancers
Discussion Leaders
-
Charlotte Bevan (Imperial College London, United Kingdom)
Speakers
-
Wilbert Zwart (Netherlands Cancer Institute, The Netherlands)
-
Theresa Hickey (University of Adelaide, Australia)
-
Myles Brown (Dana-Farber Cancer Institute, United States)
Tumor Immunology and Dormancy
Discussion Leaders
-
Luke Selth (Flinders University, Australia)
Speakers
-
Katherine Aird (University of Pittsburgh, United States)
-
John Lee (Fred Hutchinson Cancer Center, United States)
-
Maria Vivanco (CIC bioGUNE, Spain)
The Evolving Role of Tumor Microenvironment in Cancer Progression
Discussion Leaders
-
Daniel Frigo (University of Texas MD Anderson Cancer Center, United States)
-
Saraswati Sukumar (Johns Hopkins University School of Medicine, United States)
Speakers
-
Karen Blyth (CRUK Beatson Institute, United Kingdom)
-
Walid Khaled (University of Cambridge, United Kingdom)
-
Leigh Ellis (Cedars-Sinai Medical Center, United States)
-
Joshua Lang (University of Wisconsin-Madison, United States)
Novel Targets and Clinical Trials in Hormone-Related Cancers
Discussion Leaders
-
Carlo Palmieri (University of Liverpool, United Kingdom)
Speakers
-
Elgene Lim (Garvan Institute of Medical Research, Australia)
-
Amina Zoubeidi (University of British Columbia, Canada)
Defining and Addressing the Next Big Question in Hormone-Related Cancers
Discussion Leaders
-
Luca Magnani (Imperial College London, United Kingdom)
Speakers
-
Christopher Sweeney (University of Adelaide, Australia)
-
Damir Varešlija (RCSI University of Medicine and Health Sciences, Ireland)
Translating Novel Targets in Hormone-Related Cancers Into the Industry Setting
Discussion Leaders
-
Jennifer Richer (University of Colorado Anschutz Medical Campus, United States)
-
Massimo Loda (NewYork-Presbyterian/Weill Cornell Medical Center, United States)
Speakers
-
Ciara Metcalfe (Genentech, United States)
-
Scott Tomlins (Strata Oncology / University of Michigan, United States)
The GRC Power Hour™
Organizers
-
Karen Knudsen (American Cancer Society, United States)